Two Sigma Advisers’s Astrana Health ASTH Stock Holding History

Two Sigma Advisers’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,500	Closed	-$236K	–	2234
2025 Q4	$236K	Buy	+9,500	New	+$252K	﹤0.01%	2057
2022 Q4	–	Sell	-10,300	Closed	-$402K	–	2726
2022 Q3	$402K	Sell	10,300 -18,200	-64%	-$833K	﹤0.01%	1939
2022 Q2	$1.1M	Sell	28,500 -14,300	-33%	-$544K	﹤0.01%	1553
2022 Q1	$2.08M	Buy	42,800 +22,500	+111%	+$1.16M	0.01%	1234
2021 Q4	$1.49M	Buy	20,300 +2,300	+13%	+$189K	﹤0.01%	1337
2021 Q3	$1.64M	Sell	18,000 -5,900	-25%	-$502K	﹤0.01%	1360
2021 Q2	$1.5M	Sell	23,900 -30,300	-56%	-$1.12M	﹤0.01%	1442
2021 Q1	$1.47M	Buy	54,200 +5,900	+12%	+$142K	﹤0.01%	1429
2020 Q4	$882K	Buy	48,300 +18,200	+60%	+$327K	﹤0.01%	1621
2020 Q3	$540K	Buy	+30,100	New	+$519K	﹤0.01%	1789

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Two Sigma Advisers's ASTH Position: Q1 2026 in Review

Two Sigma Advisers sold out of Astrana Health (ASTH) in Q1 2026, closing a stake of 9,500 shares — an estimated $236K sold.

Two Sigma Advisers first reported a position in ASTH in Q3 2020 and held it in 10 quarters. The position peaked at $2.08M in Q1 2022. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

Two Sigma Advisers reported no remaining Astrana Health position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 9,500 Astrana Health shares in Q1 2026, an estimated $236K.
Two Sigma Advisers first reported a position in Astrana Health in Q3 2020 and held it in 10 quarters.
Two Sigma Advisers's Astrana Health position peaked at $2.08M in Q1 2022.
171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.